58198-1099 : Zobuxa 22.7 mg Oral Tablet
| NDC: | 58198-1099 |
| Labeler: | Novartis Animal Health Us, Inc. |
| Drug Name: |  Zobuxa |
| Rev. Date: |
Appearance:
| Shapes: |
Round |
| Colors: |
 Brown |
| Size (mm): | 6 |
| Segments: * | 2 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 2 indicates a scored pill which can be broken into 2 equal pieces. | |
Active Ingredients:
- Enrofloxacin
Inactive Ingredients:
- Lactose Monohydrate
- Cellulose, Microcrystalline
- Povidones
- Croscarmellose Sodium
- Magnesium Stearate
Related Products:
Based on records with the same trade name.- 58198-1103 Zobuxa 68 mg Oral Tablet by Novartis Animal Health Us, Inc.
- 58198-1107 Zobuxa 136 mg Oral Tablet by Novartis Animal Health Us, Inc.
- 58198-1109 Zobuxa 272 mg Oral Tablet by Novartis Animal Health Us, Inc.
- 58198-5570 Zobuxa 22.7 mg Oral Tablet by Elanco Us Inc.
- 58198-5572 Zobuxa 136 mg Oral Tablet by Elanco Us Inc.
- 58198-5576 Zobuxa 272 mg Oral Tablet by Elanco Us Inc.
- 58198-5578 Zobuxa 68 mg Oral Tablet by Elanco Us Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 58198-0705Next: 58198-1103 >
Related Discussions:
22.7mg Enrofloxacin 2x a day
Enrofloxacin has been taken for 5 days and the symptoms are not better: hard tummy, eating grass, throwing up, drinking ...
Enrofloxacin has been taken for 5 days and the symptoms are not better: hard tummy, eating grass, throwing up, drinking ...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.